From Wikipedia, the free encyclopedia

Carol A. Nacy (born 1948) is a microbiologist and immunologist focused on the immune response of bacterial and parasitic disease. [1] [2]

Education and academic career

Nacy did her undergraduate and PhD studies at Catholic University in Washington, DC receiving her degree in 1976. [3] [4] She did her postdoc work at the Walter Reed Army Institute of Research in the Department of Rickettsial Diseases and then became a staff scientist at the same institute for 17 years. [5] Her research concerned the understanding and treatment of a number of infections including those caused by Francisella tularensis and Leishmania major. [2]

Industrial career

Nacy founded Sequella in 1997 and continues as CEO. [5] Sequella focuses on clinical stage antibiotic development, in particular against Mycobacterium tuberculosis (TB). [6]

Awards and honors

Nacy was the president of the American Society of Microbiology (1996-1997) [1] and the Society for Leukocyte Biology (1992). [7] She was awarded the Lifetime Achievement Award in Science at Catholic University in 2002. Women in BIO [8] named her Entrepreneur of the Year (2004) and honored her with a Special Outstanding Achievement Award for Clinical Trials (2007). In December 2009 she was awarded the Humanitarian Award, Hope is a Vaccine, by the Global Alliance for Immunization against Aids (GAIA) for her work to create new drugs for TB. [4] [9]

Personal life

Nacy is married to Monte S. Meltzer, M.D., has 5 children and 3 grandchildren. [4]

References

  1. ^ a b Yee, Karen. "LibGuides: Center for the History of Microbiology/ASM Archives (CHOMA): Reference Documents". lib.guides.umbc.edu. Retrieved 2020-07-16.
  2. ^ a b Many faces, many microbes : personal reflections in microbiology. Atlas, Ronald M., 1946-. Washington, D.C.: ASM Press. 2000. ISBN  1-55581-190-6. OCLC  43287411.{{ cite book}}: CS1 maint: others ( link)
  3. ^ "Carol Nacy". Retrieved July 16, 2020.
  4. ^ a b c Immunology 2010. "Nacy biography" (PDF). Archived (PDF) from the original on 2020-07-16. Retrieved July 16, 2020.{{ cite web}}: CS1 maint: numeric names: authors list ( link)
  5. ^ a b "Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance BioBuzz". BioBuzz. 2018-08-27. Retrieved 2020-07-16.
  6. ^ "Sequella Overview". www.sequella.com. Retrieved 2020-07-16.
  7. ^ "Society of Leukocyte Biology newsletter" (PDF). Archived (PDF) from the original on 2020-07-17. Retrieved July 16, 2020.
  8. ^ "Women In Bio". Women In Bio. Retrieved 2020-07-16.
  9. ^ "2009 Hope is a Vaccine Award Ceremony". Gaia Vaccine Foundation. Retrieved 2020-07-16.